The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. repeated claims we have written about before on vaccines and chronic ...

The Trump administration is poised to supercharge America’s appetite for supplements.

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

But the poultry that went into these dishes hadn't come from a farm — it was grown from animal cells in a lab. Local ...

Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

During his confirmation hearing before the Senate Finance Committee on Wednesday, Robert F. Kennedy Jr. tackled a topic of ...

Here’s what to know about the Trump administration’s order and which information is still available to California residents.

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

"Walking back REMS has significantly increased safety risks for women. And so from our perspective, as directed by the ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...